Stock ZALICUS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Zalicus Inc Nasdaq

Equities

US98887C1053

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Zalicus Inc
2018 Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc. CI
2018 Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q). CI

Business Summary

EPIRUS Biopharmaceuticals, Inc. is in bankruptcy.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 26,184,349 26,184,349 ( 100.00 %) 0 100.00 %

Company contact information

EPIRUS Biopharmaceuticals, Inc.

699 Boylston Street 8th floor

02116, Boston

+617-600-3497

address Zalicus Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+50.14% 54.63B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-4.84% 39.92B
LONZA GROUP AG Stock Lonza Group AG
+37.18% 38.82B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+15.67% 26.86B
CELLTRION, INC. Stock Celltrion, Inc.
-12.56% 26.22B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.59% 18.78B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.59% 12.21B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+1.88% 12.16B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.93% 11.94B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. EPRSQ Stock
  4. Stock
  5. Company Zalicus Inc